News Releases
Mar 1 2021
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021
Feb 22 2021
Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion Plan
Feb 3 2021
Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
Dec 14 2020
Avid Bioservices Announces Closing of Public Offering of Common Stock
Dec 10 2020
Avid Bioservices Announces Pricing of Public Offering of Common Stock
Dec 9 2020
Avid Bioservices Announces Proposed Public Offering of Common Stock
Dec 7 2020
Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
Dec 2 2020
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
Dec 1 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Nov 24 2020
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020